Skip to main content
SpringerLink
Log in

Transfer factor 1993: New frontiers

  • Chapter
Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques

Abstract

Adoptive transfer of antigen-specific cell-mediated immunity in humans, first demonstrated by Lawrence [1] in 1949, opened a new avenue of research that has led both to increased understanding of basic immune mechanisms and to the development of many forms of immunomodulant therapy, alone or in combination with other immu-notherapeutic or chemotherapeutic agents. Lawrence originally showed that transfer of intact viable lymphocytes from a normal tuberculin skin test-positive donor for a given antigen to a normal recipient, skin test-negative for that antigen, resulted in a conversion (“transfer”) of the recipient to skin-test positivity; however, this observation created little interest in the immunologic community for several reasons. In 1955, the lymphocyte was mentioned for the first time as an immunologic organ. (Before this, the lymphocyte had been studied in hematologic rather than in immunologic terms.)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. H. S. Lawrence: The cellular transfer of cutaneous hypersensitivity to tuberculin in man. Proc. Soc. Exp. Biol. Med., 71, 516 (1949).

    CAS  PubMed  Google Scholar 

  2. A. Joffy: The Anatomy of the Lymphoid System, 3rd ed., Bristol, England (1955).

    Google Scholar 

  3. J. F. A. P. Miller: Immunologic significance of the thymus in adult mouse. Nature 195, 1318 (1962).

    Article  Google Scholar 

  4. H. S. Lawrence: The transfer in humans of delayed skin sensitivity to streptococcal M substance and to tuberculin with disrupted leukocytes. J. Clin. Invest., 34, 219 (1955).

    Article  CAS  PubMed  Google Scholar 

  5. F. Karush and H. Eisen: Delayed hypersensitivity is due to an antibody of high afinity. Science 136 page 103–1034 (1962).

    Article  Google Scholar 

  6. H. H. Fudenberg and H. L. Fudenberg: Transfer Factor: Past, Present, and Future in Annual Review of Pharmacology and Toxicology, p. 475–516, ed. E. Jucker, Birkhäuser Verlag; Basel, Switzerland (1989).

    Google Scholar 

  7. A. S. Levin, L. E. Spitler, D. P. Stites, and H. H. Fudenberg: Wiskott-Aldrich Syndrome, a genetically determined cellular immunologic deficiency: clinical and laboratory responses the therapy with transfer factor. Proc. Natl. Acad. Sci., USA 67, 821 (1970).

    Article  CAS  PubMed  Google Scholar 

  8. L. E. Spitler, A. S. Levin, D. P. Stites, H. H. Fudenberg, B. Pirofsky, C. S. August, E. R. Stiehm, W. H. Hitzig, R. A. Gatti: The Wiskott-Aldrich syndrome. Results of transfer factor therapy. Jour. Clin. Invest., 51, 3216–24 (1972).

    Article  CAS  Google Scholar 

  9. H. H. Fudenberg, C. L. Smith: Immunomodulation and immunotherapy: an overview of biologic and synthetic agents and their effects on the human immune system. EOS Riv. Immunol. Immunopharmacol., 1, 3–11.

    Google Scholar 

  10. G. B. Wilson and H. H. Fudenberg: Is controversy about “transfer factor” nearing an end? Immunol. Today, 4, 157 (1983).

    Article  Google Scholar 

  11. R. Ashorn, K. Krohn: Personal communication (1976).

    Google Scholar 

  12. G. B. Wilson, H. T. Jonsson, Jr., P. V. Halushka, B. P. Garner, M.N. Berkaw, et. al.: Contribution of prostaglandins to the biological activity of dialyzable leukocyte extracts containing transfer factor activity in Immune Regulators in Transfer Factor, p. 137, ed. A. Khan, C. H. Kirkpatrick, N. O. Hill. Academic Press New York (1979).

    Google Scholar 

  13. G. B. Wilson, T. M. Welch, D. R. Knapp, A. Horsmanheimo, and H. H. Fudenberg: Characterization of Tx, an active subfraction of human dialyzable transfer factor. I. Identification of the major component of TF, a precursor of Tx, as hypoxanthine. Clin. Immunol. Immunopathol. 8, 551 (1977).

    Article  CAS  PubMed  Google Scholar 

  14. D. R. Burger, A. A. Vandenbark, D. Daves, W. A. Anderson, Jr., R. M. Vetto, P. Finke: Nicotinamide suppression of lymphocyte transformation with a component identified in human transfer factor. J. Immun. 117, 797–801 (1976).

    CAS  PubMed  Google Scholar 

  15. H. H. Fudenberg: Dialyzable transfer factor in the treatment of osteosarcoma: an analytical review. Ann. NY Acad. Sci., 277, 245–58 (1976).

    Article  Google Scholar 

  16. V. E. M. Rosso, D. S. Secondo, P. Pontecucchi, G. Piccolo, et al.: Purification of an immunosuppressive factor from dialyzable leukocyte extracts in Recent Advances of Transfer Factor and Dialyzable Leukocyte Extracts, p. 73–9, ed. T. Fujisaw et al., Maruzen Co. Ltd., Japan (1992).

    Google Scholar 

  17. G. B. Wilson, G. V. Paddock, and H.H. Fudenberg: Bovine “transfer factor”: an oligoribonucleotide which initiates antigen-specific lymphocyte responsiveness, Thymus, 4, 335 (1982).

    CAS  PubMed  Google Scholar 

  18. C. H. Kirkpatrick: Purification and composition of transfer factors. Molecular Immunology, 29, 167 (1992).

    Article  PubMed  Google Scholar 

  19. S. J. Rozzo, J. Boymel, C. H. Kirkpatrick: Composition and purification of transfer factors in Recent Advances of Transfer Factor and Dialyzable Leukocyte Extracts, p. 11–22, et T. Fujisaw et al., Maruzen Co. Ltd., Japan (1992).

    Google Scholar 

  20. C. H. Kirkpatrick: Personal communication (1992).

    Google Scholar 

  21. G. Metzner: Personal communication (1993).

    Google Scholar 

  22. I. Schroder, H. Werner, H. Schiller, A. Matz, J. Rovensky, G. Vietinghoff: On the characterization of the biological activity of DLE fractions. Comparison of transfer factor preparations of different origin in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 51–6, ed T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi. Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  23. Z. Wan, Maojifang, Wanghua, A. Yang, F. Guo: Antigen-dependent activities and physico-chemical characterization of specific goat’s transfer factor to human gastric adenocarcinoma in Research and Application of Transfer Factor and DLE, p. 17–24, ed. Huo Bao-lai, Wang Ru-zhang, Zou Zhaofen. Xueyuan Press; Beijing, China (1989).

    Google Scholar 

  24. Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi. Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  25. H. H. Fudenberg, R. Keller, G. B. Wilson: Unpublished observations (1980).

    Google Scholar 

  26. H. H. Fudenberg, H. L. Fudenberg: Transfer Factor: Past, Present, and Future, p. 551–598, in Research and Applications of Transfer Factor and DLE, ed. B. Huo, R. Wang, Z. Zou, Beijing, China, pub. Xue Yuan Press (1989).

    Google Scholar 

  27. D. Viza, J. M. Vich, J. Phillips, F. Rosenfeld: Orally administered specific transfer factor for the treatment of herpes infections. Lymphok. Res., 4, 27–30 (1985).

    CAS  Google Scholar 

  28. W. S. Jeter, R. Kibler, C. A. L. Stephens: Oral administration of dialyzable transfer factor to tuberculin to human volunteers. J. Reticulo Endothel. Soc, 22, 46a (1977).

    Google Scholar 

  29. O. Tatsuzawa, M. Nagata, Y. Wado, T. Satoh, Y. Koike, K. Nihei, N. Wada: Clinical application of a transfer factor suppository in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 243–6, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi, Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  30. A. N. Matz, H. Werner, S. N. Skopinskaya, N. P Perepechkina, O. V. Perelygina, N. A. Pereverzev: Amplification of the transfer factor activity of lymphocytic ultrafiltrate incorporated into liposomes in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 57–66, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi. Maruzen Co., Ltd., Tokyo, Japan (1992).

    Google Scholar 

  31. G. S. Gordon, Personal communication (1976).

    Google Scholar 

  32. G. B. Wilson and H. H. Fudenberg: Leukocyte migration inhibition as a method for assaying transfer activities in Lymphokines, vol. IV, p. 107, ed. E. Pick and M. Landy. Academic Press; New York (1981).

    Google Scholar 

  33. Discussion in Immune Regulators in Transfer Factor, ed. A. Khan, C. H. Kirkpatrick, N. O. Hill. Academic Press; New York (1976).

    Google Scholar 

  34. P. M. Hoffman, L. E. Spitler, M. Hsu, and H. H. Fudenberg: Leukocyte migration-inhibition in agarose. Cell Immunol., 18, 21 (1975).

    Article  CAS  PubMed  Google Scholar 

  35. H. H. Fudenberg, G. B. Wilson, and K. Y. Tsang: Evaluation of potency and predictability of clinical response to DLE containing transfer factor in Immunomodulation and Thermotherapy, p. 141, ed. H. H. Fudenberg and P. Pontiggia. Acta Medica; Rome, Italy (1983).

    Google Scholar 

  36. J. Koistininen, J. Leikola: Personal communication (1976).

    Google Scholar 

  37. G. B. Wilson, H. H. Fudenberg: Unpublished observations (1976).

    Google Scholar 

  38. H. H. Fudenberg, G. B. Wilson, R. H. Keller, J. F. Metcalf, E. E. Paulling, et al.: Clinical applications of the leucocyte migration inhibition assay — new methods for determining transfer factor potency and for predicting clinical response in Immunobiology of Transfer Factor, p. 293–310, ed. C. H. Kirkpatrick, H. S. Lawrence, D. R. Burger. Academic Press; New York (1983).

    Google Scholar 

  39. G. B. Wilson, H. H. Fudenberg, M. Horsmanheimo: Effects of Dialyzable Leukocyte Extracts (DLE) with Transfer Factor (TF) activity on leukocyte migration in vitro. I. Antigen-dependent inhibition and antigen-independent inhibition and enhancement of migration. J. Lab. Clin. Med., 93, 800 (1979).

    CAS  PubMed  Google Scholar 

  40. G. B. Wilson and H. H. Fudenberg: Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. II. Separation and partial characterization of the components in DLE producing antigen-dependent and antigen-independent effects. J. Lab. Clin. Med. 93, 819 (1979).

    CAS  PubMed  Google Scholar 

  41. H. H. Fudenberg, J. M. Goust: Unpublished observations (1984).

    Google Scholar 

  42. T. M. Welch, R. Triglia, L. E. Spitler, H. H. Fudenberg: Preliminary studies on human “transfer factor” activity in guinea pigs: systemic transfer of cutaneous delayed-type hypersensitivity to PPD and SKSD. Clin. Immunol. Immunopathol., 5, 407 (1976).

    Article  CAS  PubMed  Google Scholar 

  43. E. W. Ramsey, L. J. Brandes, G. J. Goldenberg: The effect of skin testing on cellular immunity as measured in vitro by leukocyte migration inhibition. Cell. Immunol. 30, 156 (1977).

    Article  CAS  PubMed  Google Scholar 

  44. M. P. Arala-Chaves and H. H. Fudenberg: Specificity of transfer factor. Nature, 262, 1555 (1976).

    Article  Google Scholar 

  45. L. Cohen, R. S. Holzman, F. T. Valentine, H. D. Lawrence: Requirement of precommitted cells as targets for the augmentation of lymphocyte proliferation by leukocyte dialysates, J. Exp. Med., 143, 791 (1976).

    Article  CAS  PubMed  Google Scholar 

  46. M. P. Arala-Chaves, H. H. Fudenberg, Unpublished observations (1976).

    Google Scholar 

  47. M. P. Arala-Chaves, A. Silva, M. T. Porto, A. Picoto, M. T. F. Ramos, H. H. Fudenberg: In vitro and in vivo studies of the target cell for dialyzable leukocyte extracts. Evidence for recipient specificity. Clin. Immunol. Immunopathol, 8, 430 (1977).

    Article  CAS  PubMed  Google Scholar 

  48. A. A. Gottlieb, J. L. Farmer, E. Benes, A. Montgomery, C. DelSignore, R. Smith, D. Bertucci, S. Sinha: Augmentation of antigen-induced Inter-leukin-2 receptor expression and gamma-interferon production by IM-REG-1, a leukocyte derived immunomodulator in Clinical Immunology, p. 375, ed. W. Pruzanski, M. Seligmann. Elsevier; New York Amsterdam London (1987).

    Google Scholar 

  49. S. K. Singh, R. C. Sizemore, A. A. Gottlieb: Immunomodulatory components present in IMREG-1, an experimental immunosupportive biologic. Biotechnology, 6, 810–15.

    Google Scholar 

  50. A. A. Gottlieb, M. S. Gottlieb: Clinical and biological effects of IMREG-1 and IMREG-2, two immunologically active components of leukocyte dialysates in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 3–10, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi, Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  51. H. H. Fudenberg: Unpublished observations.

    Google Scholar 

  52. Peng, Li-yi, Yang Dao-li, Qi Fa-lian, Jia Bo-sen, Wang Bao-cheng, Du Gung-zu: Efficiency and immunological function observation on 100 cases malignant tumor treater with dialyzable placenta extracts in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 354–5, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi, Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  53. H. H. Fudenberg, H. L. Fudenberg: Unpublished observations (1987).

    Google Scholar 

  54. A. S. Levin, V. S. Byers, H. H. Fudenberg, J. Wybran, A. J. Hackett, et al.: Osteogenic sarcoma: Immunologic parameters before and during immunotherapy with tumorspecific transfer factor. J. Clin. Invest.; 55, 487 (1975).

    Article  CAS  PubMed  Google Scholar 

  55. J. Wybran, M. C. Carr, and H. H. Fudenberg: The human rosette-forming cell as a marker of the population of thymus-derived cells. J. Clin. Invest., 51, 2537 (1972).

    Article  CAS  PubMed  Google Scholar 

  56. J. Wybran, A. S. Levin, L. E. Spitler, and H.H. Fudenberg: Rosette-forming cells, immunologic deficiency diseases and transfer factor. New Eng. J. Med., 288, 710 (1973).

    Article  CAS  PubMed  Google Scholar 

  57. S. Horowitz, T. Groshong, R. Albrecht, R. Hong: The “active” rosette test in immunodeficiency diseases. Clin. Immunol. Immunopathol., 4, 405 (1975).

    Article  CAS  PubMed  Google Scholar 

  58. X. Jiang, W. Zhu: In vitro experimental study on the activating effect of sheep spleen transfer factor on E receptor of human T lymphocytes in Research and Application of Transfer Factor and DLE, p. 32–36, ed. Huo Bao-lai, Wang Ru-zhang, Zou Zhaofen. Xueyuan Press; Beijing, China (1988).

    Google Scholar 

  59. K. Nekam, L. Kalmar, P. Gergely, G. Kelemen, B. Fakete, and I. Lang: In vitro effect of transfer factor on active rosettes and leukocyte migration of patients with cancer. Clin. Exp. Immunol., 27, 416 (1977).

    CAS  PubMed  Google Scholar 

  60. I. L. Sargent, R. S. Myer, and H. Valdimarsson: Effects of transfer factor (TF) and thymosin on the revovery of E-rosetting capacity in trypsinised lymphocytes in Immune Regulators in Transfer Factor, p. 172, ed. A. Khan, C. H. Kirkpatrick, N. O. Hill. Academic Press; New York (1979).

    Google Scholar 

  61. K. Nekam, H. H. Fudenberg: Unpublished observations (1976).

    Google Scholar 

  62. X. Guo, Y. Li, Q. Meng: Study of production and Character of transfer factor of normal swine in Research and Application of Transfer Factor and DLE, p. 49–54, ed. Huo Bao-lai, Wang Ru-zhang, Zou Zhao-fen. Xueyuan Press; Beijing, China (1988).

    Google Scholar 

  63. J. M. Goust and H. H. Fudenberg: T-cell binding to B-lymphoid cell lines in humans: A marker for T-B cell-interaction. J. Immunol. Methods, 59, 29 (1983).

    Article  CAS  PubMed  Google Scholar 

  64. H. H. Fudenberg: In preparation (1993).

    Google Scholar 

  65. H. H. Fudenberg: Transfer factor: update (invited mini review) Proc. Soc. Exp. Med. Biol. 178, 327 (1985).

    CAS  Google Scholar 

  66. P. Dorfling, I. Schroder: Effect of the dialyzable leukocyte extract and its different fractions on the production of H2O2 and IL-1 by macrophages, p. 141–45 in Leukocyte Dialysates and Transfer Factor, ed. V. Mayer, J. Borvak. Inst. Virol., Slovak Acad. Sci.; Bratislava, Czecheslovakia (1987).

    Google Scholar 

  67. K. Nekam, H. H. Fudenberg, B. Mandi, I. Lang, P. Gergely, G. Petranyi: Resynthesis of trypsinized sheep red blood cell receptors on human lymphocytes: comparison of the effects of immunopotentiators of biological and synthetic origin in vitro. Immunopharmacology 3, 31–9.

    Google Scholar 

  68. K. Nekam, I. Lang, K. Torak, L. Kalmar, P. Gergely, and G. Petranyi: Effects of therapy with dialyzable leukocyte extracts containing transfer factor activity on antibody-dependent cytotoxic activity in humans. Clin. Immunol. Immunopathol., 13, 407 (1979).

    Article  CAS  PubMed  Google Scholar 

  69. A. Uotila, K. Krohn, K. M. Marnela, and J. Antonen: Mechanism of the in vitro augmentation of lymphocyte transformation by transfer factor and by other cellular Dialysates in Immunobiology of Transfer Factor, pp. 293–310. Eds. C. H. Kirkpatrick and H. S. Lawrence. Academic Press; New York (1983).

    Google Scholar 

  70. B. Dupont, M. Ballow, J. A. Hansen, C. Quick, E. J. Yunis, and R. A. Good: Effect of transfer factor therapy on mixed lymphocyte culture reactivity. Proc. Natl. Acad. Sci. USA 71, 867 (1974).

    Article  CAS  PubMed  Google Scholar 

  71. J. I. Gallin and C. H. Kirkpatrick: Chemotactic activity in dialyzable transfer factor. Proc. Natl. Acad. Sci. USA, 71, 498 (1974).

    Article  CAS  PubMed  Google Scholar 

  72. I. Lang, K. Nekam, P. Gergely, and G. Petranyi: Effect of in vivo and in vitro treatment with dialyzable leukocyte extracts containing transfer factor activity on human natural killer cell activity. Clin. Immunol. Immunopathol., 25, 139 (1982).

    Article  CAS  PubMed  Google Scholar 

  73. H. S. Lawrence: Transfer factor. Adv. Immunol., 11, 195 (1969).

    Article  CAS  PubMed  Google Scholar 

  74. K. Nekam, A. Perl, P. Gergely, I. Lang, R. Gonzales-Cabello, and J. Feher: Effects of dialyzable leukocyte extracts on lectin dependent cell mediated cytotoxicity in vitro in Leukocyte Dialysates and Transfer Factor, pp. 171–5, ed. V. Mayer and J. Borvak. Instit. Virol., Slovak Acad. Sci.; Bratislava, Czechoslovakia (1987).

    Google Scholar 

  75. V. S. Byers, A. S. Levin, A. J. Hackett, and H. H. Fudenberg: Tumor-specific cell-mediated immunity in household contacts of cancer patients. J. Clin. Invest., 55, 500 (1975).

    Article  CAS  PubMed  Google Scholar 

  76. H. H. Fudenberg: Transfer factor in immunodeficiencies: One man’s one-eyed perspective in Progress in Immunology II, Vol. 5, p. 215–21, ed. L. Brent, J. Holborrow, North-Holland; Amsterdam (1974).

    Google Scholar 

  77. H. H. Fudenberg, A. S. Levin, L. E. Spitler, J. Wybran, and V. Byers: The therapeutic uses of transfer factor. Hospital Practice, 9, 95–104 (1974).

    Google Scholar 

  78. H. H. Fudenberg, J. Wybran: Experimental Immunotherapy in Basic and Clinical Immunology, p. 722–36, ed. H. H. Fudenberg, D. P. Stites, J. L. Caldwell, J. V. Wells, Third Edition. Lange Medical Publications; Los Altos, California (1980).

    Google Scholar 

  79. K. Y. Tsang, H. H. Fudenberg: Transfer factor and other T cell derived factor (non-LKs). Springer Seminars in Immunopathology, Vol. 8, No. 4 (1986).

    Google Scholar 

  80. H. H. Fudenberg: Transfer factor: past, present and future. Plenary Lecture V. Intl. Symposium on Transfer Transfer. Bratislava, Czecheslovakia (1986).

    Google Scholar 

  81. C. H. Kirkpatrick and L. E. Greenberg: Treatment of chronic mucocutaneous candidiasis with transfer factor in Immune Regulators in Transfer Factor; ed. A. Khan, C. H. Kirkpatrick, N. O. Hill. Academic Press; New York (1979).

    Google Scholar 

  82. B. H. Littman, R. E. Rocklin, R. Parkman, and J. R. David; Transfer factor treatment of chronic mucocutaneous candidiasis: Requirement for donor reactivity to Candida antigen. Clin. Immunol. Immunopathol., 9, 97 (1978).

    Article  CAS  PubMed  Google Scholar 

  83. L. E. Spitler, A. S. Levin, H. H. Fudenberg: Transfer Factor II: Results of therapy, p. 449–56, in Primary Immunodeficiency Diseases in Man, ed. D. Bergsma, R. A. Good, J. Finstad, N. W. Paul. Nat. Foundation Press; White Plains, NY (1975).

    Google Scholar 

  84. R. Conte, M. Masi, G. Pizza, R. Ricci et al.: Il Transfer Factor Nel Trattamento di Quadri Clinici Diversa: Candidiasis Mucocutanea Cronica, infectioni gravi, sindrome di Behcet. La Trasfusione del Sangue, 28, 386–96 (1983).

    Google Scholar 

  85. H. Valdimarsson, J. M. Higgs, T. S. Wells, M. Yamamara, J. R. Hobbs, and P. J. L. Holt: Immune abnormalities associated with chronic mucocutaneous candidiasis. Cell. Immunol., 6, 348 (1973).

    Article  CAS  PubMed  Google Scholar 

  86. W. M. Lee, H. P. Holley, J. Stewart, and G. M. P. Galbraith: Refractory esophageal candidiasis associated with a plasma inhibitor of T-lymphocyte function: Response to plasma exchange. Am. J. Med. Sci., 292, 47 (1986).

    Article  CAS  PubMed  Google Scholar 

  87. A. Catanzero and L. E. Spitler: Clinical and immunologic results of TF therapy in coccidiomycosis, p. 477–94, in Transfer Factor: Basic Properties and Clinical Applications, ed. M. S. Asher, A. A. Gottlieb, C. H. Kirkpatrick. Academic Press; New York (1976).

    Google Scholar 

  88. B. Myrvang, T. Godal, D. S. Ridley, S. S. Froland, and Y. K. Song: Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens through out the clinical and histopathological spectrum of leprosy. Clin. Exp. Immunol., 14, 541 (1973).

    CAS  PubMed  Google Scholar 

  89. W. E. Bullock, J. P. Fields, M. W. Bandvias: An evaluation of transfer factor as immunotherapy for patients with lepromatous leprosy. New Eng. J. Med., 287, 10 53 (1972).

    Google Scholar 

  90. R. C. Hastings, M. J. Morales, E. J. Shannon, and R. R. Jacobson: Preliminary results in the safety and efficacy of transfer factor in leprosy in Transfer Factor: Basic Properties and Clinical Applications, p. 465–76, ed. M. S. Asher, A. A. Gottlieb, C. H. Kirkpatrick. Academic Press; New York (1976).

    Google Scholar 

  91. X. Dang, Z. Jin: Study on the treatment of leprosy with transfer factor in Research and Application of Transfer Factor and DLE, p. 411–23, ed. Huo Bao-lai, Wang Ru-zhang, Zou Zhao-fen. Xueyuan Press; Beijing, China (1989), p. 325–9.

    Google Scholar 

  92. P. G. Lesser, L. Margarido, W. Bolda, S. G. Sartori, W. A. Hares, C. A. Freire, R. Fleury, M. R. Montenegro, W. Leser, C. K. Naspitz: Cell mediated immunity in patients with Virchowian Hanseniasis before and after treatment with transfer factor, p. 3–27, pub. Hansenol. Int. J., 5(1), 3–27 (1980).

    Google Scholar 

  93. M. Horsmanheimo and H. H. Fudenberg: Unpublished observations (1981).

    Google Scholar 

  94. J. Pekarek, K. Cech, K. Barnet: The clinical use of specific transfer factors in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts; p. 256–63, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Konatsu, Y. Yamaguchi. Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  95. G. B. Wilson, J. F. Metcalf, Jr., and H. H. Fudenberg: Treatment of Mycobacterium-fortuitum pulmonary infection with “transfer factor” (TF): New methodology for evaluating TF potency and predicting clinical response. Clin. Immunol. Immunopathol., 23, 478 (1982).

    Article  CAS  PubMed  Google Scholar 

  96. J. F. Metcalf, J. F. John, Jr., G. B. Wilson, H. H. Fudenberg, and R. A. Harley: Mycobacterium fortuitum pulmonary infection associated with an antigen-selective defect in cellular immunity. Am. J. Med., 71, 485 (1981).

    Article  CAS  PubMed  Google Scholar 

  97. M. K. Sharma, F. Anaraki, and F. Ala: Preliminary results of transfer factor therapy of persistent cutaneous leishmania infection. Clin. Immunol. Immunopathol., 12, 183 (1979).

    Article  CAS  PubMed  Google Scholar 

  98. M. Sharma, R. Firouz, and F. Ala: Transfer factor therapy in human cutaneous leishmania infection (CLI): A double-blind clinical trial in Immune Regulators in Transfer Factor, p. 563–70, ed. A. Khan, C. H. Kirkpatrick, N. O. Hill. Academic Press; New York (1979).

    Google Scholar 

  99. O. Delgado, E. L. Romano, E. Belfort, F. Pifano, J. V. Scorza, and Z. Rojas: Dialyzable leukocyte extract therapy in immunodepressed patients with cutaneous leishmaniasis. Clin. Immunol. Immunopathol., 19, 351 (1981).

    Article  CAS  PubMed  Google Scholar 

  100. S. E. Maddison, M. D. Hicklin, B. P. Conway, I. J. Cagan: Transfer factor: Delayed hypersensitivity to schistosomiasis and tuberculin in Macaca Mulatta. Science 178, 757–8.

    Google Scholar 

  101. S. E. Maddison, M. D. Hicklin, I. G. Keegan: Schistosoma mansoni: reduction in clinical manifestations and in worm burdens conferred by serum and transfer factor from immune or normal rhesus monkeys. Expl. Parasit., 39, 29–39 (1976).

    Article  CAS  Google Scholar 

  102. J. G. Ross, W. G. Halliday: Investigations of transfer factor activity in the transfer of immunity to Trichostrongylus acei infections in sheep. Res. Vet. Sci., 26, 41–6 (1979).

    CAS  PubMed  Google Scholar 

  103. J. G. Ross, J.L. Duncan, W. G. Halliday: Investigation of Haemonchus contortus infections in sheep: comparison of irradiated larvae and transfer factor treatment. Res. Vet. Sci., 27, 258–9 (1979).

    CAS  PubMed  Google Scholar 

  104. E. Louie, W. S. Borkowsky, P. H. Klesius, T. B. Haynes, S. Gordon et al.: Treatment of Cryptosporidiosis with oral bovine transfer factor. Clin. Immunol. Immunopathol., 44(3) 329 (1987).

    CAS  Google Scholar 

  105. A. McMeeking, W. Borkowski, P. H. Klesius, S. Bonk, R. S. Holzman, H. S. Lawrence: A controlled trial of bovine dialyzable leukocyte extract for cryptosporidiosis in patients with AIDS. J. Infect Dis., 161, 108–12 (1990).

    Article  CAS  PubMed  Google Scholar 

  106. R. W. Steele, M. G. Myers, and M. M. Vincent: Transfer factor for the prevention of varicella zoster infection in childhood leukemia. New Engl. J. Med., 303, 355 (1980).

    Article  CAS  PubMed  Google Scholar 

  107. H. H. Fudenberg: Ophthalmologic Herpes Zoster: Complete remission in six hours with dialyzable transfer factor. J. Clin. Lab. Immunol., 18, 49 (1985).

    Google Scholar 

  108. D. Viza, J. M. Vich, J. Phillips, F. Rosenfeld: Orally administered specific transfer factor for the treatment of herpes infections. Lymphok. Res., 4, 27–30 (1985).

    CAS  Google Scholar 

  109. D. Viza, J. M. Vich, J. Phillips, F. Rosenfeld, D. A. L. Davies: Specific transfer fact or protects mice against lethal challenge with herpes simples virus. Cell. Immun., 100, 555–62 (1986).

    Article  Google Scholar 

  110. D. Viza, J. M. Vich, J. Phillips, D. A. L. Davies: Use of specific transfer factor for the prevention or the treatment of herpes infections in mice and in man. J. Exp. Path., 3, 407–420 (1987).

    CAS  Google Scholar 

  111. V. Mayer, S. Necas, J. Borvak, M. Horvathova: Marked therapeutic effect of human leucocyte ultrafîltrate in herpes zoster: association with cell-mediated immune response induction in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 231–7, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi. Maruzen Co., Ltd., Tokyo, Japan (1992).

    Google Scholar 

  112. H. Qi, X. Zhu, C. Uy, Z. Wan, C. Su: HSV-1 specific transfer factor for the treatment of herpes simplex keratitis in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 227–30, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi. Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  113. R. Cabeza-Quiroga, S. Estrada-Parra, L. Padierna-Olivos, R. Ysla-Garcia: Effects of DLE in patients with herpes in Research and Application of Transfer Factor and DLE, p. 292–305, ed. Huo Bao-lai, Wang Ru-zhang, Zou Zhao-fen. Xueyuan Press; Beijing, China (1989).

    Google Scholar 

  114. Z. Li: Studies of Hepatitis B virus specific DLE in Research and Application of Transfer Factor and DLE, p. 214–24, ed. Huo Bao-lai, Wang Ru-zhang, Zou Zhaofen. Xueyuan Press; Beijing, China (1989).

    Google Scholar 

  115. Zhang Guang-Shu, Hou Xian-Rong, Zhao Hui-Chuan, Du Qing-Ling, Wang Gen-Ting, Lin Gua-Xian: Evaluation of the effects of acute hepatitis B treated with specific placenta transfer factor in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 217–21, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi. Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  116. G. Metzner, M. Reinhardt, H. M. R. K. Muschner, W. Franke: Effect of DLE in patients suffered from chronic active chronic persistent HBs-antigen-positive hepatitis in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 204–12, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi. Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  117. Wu Jing-xin, Liu Ju-xiang: Treatment of hepatitis B with bovine spleen transfer factor in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 213–6, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi, Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  118. G. Zhang, Z. Li, X. Y. Wang: Survey on the treatment of 200 CAH cases with specific transfer factor extracted from HBVM positive placenta in Research and Application of Transfer Factor and DLE, p. 411–23, ed. Huo Bao-lai, Wang Ruzhang, Zou Zhao-fen. Xueyuan Press; Beijing, China (1989).

    Google Scholar 

  119. Z. Li: Clinical application of transfer factor in China in Research and Applications of Transfer Factor and DLE, p. 478–90, ed. Huo Bao-lai, Wang Ru-zhang, Zou Zhao-fen. Xueyuan Press; Beijing, China (1989).

    Google Scholar 

  120. G. Mazzella, M. Ronchi, N. Villanova, A. A. Mohamed, G. Pizza, C. De-Vinci, D. Viza, E. Roda, L. Barbara: Treatment of chronic B-virus hepatitis with specific transfer factor. J. Exp. Pathol., 3, 421–3 (1987).

    CAS  PubMed  Google Scholar 

  121. K. Sumiyama, M. Kobayashi, M. Koike: Combined therapy with transfer factor and large dose SNMC in juvenile chronic hepatitis Type B (HBe Ag positive) in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 197–203, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi. Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  122. B. Huo, J. Wu: Clinical observation on the effects of dialyzable leukocyte extracts in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 304–10, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi, Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  123. G. Zhang, Z. Li, X. Wang: Treatment of chronic hepatitis B with specific transfer factor extracted from HBVM positive spleen in Research and Application of Transfer Factor and DLE, p. 243–52, ed. Huo Bao-lai, Wang Ru-zhang, Zou Zhao-fen. Xueyuan Press; Beijing, China (1989).

    Google Scholar 

  124. S. Matsumato, Y. Takasachi, Y. Sakiyama: Treatment of chronic hepatitis B with high dose of specific dialyzable leukocyte extracts in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 30–9, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi, Maruzen Co., Ltd., Tokyo, Japan (1992).

    Google Scholar 

  125. S. T. Schulman, J. M. Hutto, E. M. Ayoub: A double-blind of evaluation of transfer factor of HBs Ag-positive chronic aggressive hepatitis: preliminary report of efficacy. Cell Immunol., 43, 352 (1979).

    Article  Google Scholar 

  126. p. 27 China #

    Google Scholar 

  127. Z. Li: Personal communication (1990).

    Google Scholar 

  128. G. Pizza, D. Viza, A. Roda, R. Aldini, E. Roda, L. Barbara: Transfer Factor for the treatment of chronic active hepatitis. N. Eng. J. Med., 300, 1332 (1979).

    CAS  Google Scholar 

  129. E. Roda. D. Viza, G. Pizza, L. Mastroroberto, J. Phillips, C. De Vinci, L. Barbara: Transfer Factor for the treatment of HBsAg-positive chronic active hepatitis. P. Soc. Exp. Med., 178, 468–475 (1985).

    CAS  Google Scholar 

  130. C. U. Kyong, G. B. Wilson, H. H. Fudenberg, J. M. Goust, P. Richardson, J. Eckerd: Chorioretinitis with a combined defect in T and B lymphocytes and granulocytes: A new syndrome successfully treated with dialyzable leukocyte extracts (Transfer Factor). Am. J. Med., 68, 955 (1980).

    Article  CAS  PubMed  Google Scholar 

  131. J. Prochazkova, E. Parizkova, J. Horacek, O. Pozler, V. Chylkova, et al.: Clinical and immunological improvement in infants with HCMV infection treated with dialyzable leukocyte extract, p. 403–411 in Leukocyte Dialysates and Transfer Fact or, ed. V. Mayer, J. Borvak, Inst. Virol. Slovak Acad. Sci.; Bratislava, Czechoslovakia (1987).

    Google Scholar 

  132. Discussion in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi. Maruzen Co., Ltd., Tokyo, Japan (1992).

    Google Scholar 

  133. F. K. Nkrumah, G. Pizza, D. Viza, J. Phillips, C. DeVinci, P. H. Levine: Regression of progressive lymphoadenopathy in a young child with acute cytomegalovirus (CMV) infection following administration of transfer factor with specific anti-CMV activity. Lymphokine Res., 4, 237–241 (1985).

    CAS  PubMed  Google Scholar 

  134. J. F. Jones, L. L. Minnich, W. S. Jeter, R. F. Pritchett, V. A. Fulginiti, R. J. Wedgwood: Treatment of childhood combined Epstein-Barr virus/cytomegalovirus infection with oral bovine transfer factor. Lancet, 18; 2(8238), 122–4 (1981).

    Article  Google Scholar 

  135. D. Viza, C. Boucheix, J. P. Cesarini, D. V. Ablashi, G. Armstrong, P. Levine, G. Pizza: Characterization of a human lymphoblastoid cell line, LDV/7, used to replicate transfer factor and immune RNA. Bio. Cell, 46, 1–10 (1982).

    Google Scholar 

  136. J. F. Jones, G. Pizza, C. DeVinci: Infectious mononucleosis: immunotherapy woth EBV-specific transfer factor. J. Exp. Pathol., 3, 399–406 (1987).

    CAS  PubMed  Google Scholar 

  137. C. De Yuan, X. Ming-Rong, L. Hua-Ran, W. Huy-Min, et al.: The development of specific transfer factor for EB virus in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 247–52, ed. T. Fuji-sawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi, Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  138. D. Viza, A. Lefesvre, M. Patrasco, J. Phillips, N. Hebbrecht, G. Laumond, J. M. Vich: A preliminary report on three AIDS patients treated with anti-HIV specific transfer factor. J. Exp. Path., 3, 653–9 (1987).

    CAS  Google Scholar 

  139. D. Viza, J. M. Vich, A. Minarro, D. V. Albashi, S. Z. Salahuddin: Soluble extracts from a lymphoblastoid cell line modulate SAIDS evolution. J. Virol. Met., 21, 241–253 (1988).

    Article  CAS  Google Scholar 

  140. J. Borvâk, H. Schmidtmayerová: Inhibition of HIV-1 reverse transcriptase activity by HPLC fractions of lysed leukocyte ultrafiltrate in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 87–94, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi, Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  141. R. E. Wolf, H. H. Fudenberg, T. M. Welch, L. E. Spitler, and M. Ziff: Treatment of Behçet’s syndrome with transfer factor. J. Am. Med. Assoc, 238, 869 (1977).

    Article  CAS  Google Scholar 

  142. K. Freiburger and H. H. Fudenberg: Behçet’s Disease: Pitfalls in therapy and diagnosis. Hosp. Pract., 15, 40 (1980).

    Google Scholar 

  143. L. R. Heim: Atopic dermatitis, specific virus infections, and Behçet’s syndrome: transfer factor therapy in Immune Regulators in Transfer Factor, p. 531–6, ed. A. Khan, C. H. Kirkpatrick, N. O. Hill. Academic Press; New York (1979).

    Google Scholar 

  144. J. J. Hooks: Possibility of a viral etiology in recurrent aphthous ulcers and Behçet’s syndrome. J. Oral Pathol., 7, 353 (1978).

    Article  CAS  PubMed  Google Scholar 

  145. T. Lehner: Immunologic aspects of recurrent oral ulceration and Behçet’s syndrome. J. Oral Pathol. 7, 424 (1978).

    Article  CAS  PubMed  Google Scholar 

  146. G. M. P. Galbraith, H. H. Fudenberg: Transfer factor in Dermatologic Immunology and Allergy, p. 889–98, ed. J. Stone. Mosby; St. Louis, Mo (1985).

    Google Scholar 

  147. G. M. P. Galbraith, H. H. Fudenberg: Unpublished observations (1987).

    Google Scholar 

  148. H. H. Fudenberg: In preparation.

    Google Scholar 

  149. A. Rook: Common baldness and alopecia areata in Recent Advances in Dermatology, ed. A. Rook, pp. 223–47. Churchill Livingstone; New York (1977).

    Google Scholar 

  150. G. M. P. Galbraith, B. H. Thiers, D. B. Vasily, and H.H. Fudenberg: Immunological profiles in alopecia areata. Br. J. Dermatol., 110, 163 (1984).

    Article  CAS  PubMed  Google Scholar 

  151. F. Fomatsu: Effects of DLE and inosine fraction of DLE on lymphocytes in Research and Application of Transfer Factor and DLE, p. 14–16, ed. Huo Bao-lai, Wang Ru-zhang, Zou Zhao-fen. Xueyuan Press; Beijing, China (1989).

    Google Scholar 

  152. K. Bamet, V. Hribalová, J. Pekárek, K. Cech: The effect of DLE and isoprinosine and guinea pig thymocytes in the comitogentic test in Research and Application of Transfer Factor and DLE, p. 86–94, ed. Huo Bao-lai, Wang Ru-zhang, Zou Zhao-fen. Xueyuan Press; Beijing, China (1989).

    Google Scholar 

  153. H. H. Fudenberg, A. Tsang: In preparation.

    Google Scholar 

  154. R. E. Wolff, H. H. Fudenberg, and J. N. Gilliam: Transfer factor therapy in a case of pemphigus vegetans associated with chronic mucocutaneous candidiasis. Clin. Immunol. Immunopathol., 10, 292 (1978).

    Article  Google Scholar 

  155. H. H. Fudenberg, A. J. Strelkauskas, J. M. Goust, D. Osborne, D. Fort, and D. Vasily: “Discoid” lupus erythematosis: Dramatic clinical and immunological response to dialyzable leukocyte extract (Transfer Factor). Trans. Assoc. Am. Physicians, 94, 279 (1981).

    CAS  PubMed  Google Scholar 

  156. D. B. Vasily, F. Miller, H. H. Fudenberg, J. M. Goust, and G. B. Wilson: Epidermodysplasia verriciformis: response to therapy with dialyzable leukocyte extract (transfer factor) derived from household contacts. J. Clin. Lab. Immunol., 14, 49 (1984).

    CAS  PubMed  Google Scholar 

  157. Deleted in proof.

    Google Scholar 

  158. Deleted in proof.

    Google Scholar 

  159. J. M. Dwyer, E. Topper, and R. Sherwin: The prevention of diabetes in BB rats by the administration of transfer factor in 5th International Symposium on Transfer Factor, ed. V. Mayer, J. Borvak, pp. 275–84. Inst. Virol. Slovak Acad. Sci.; Bratislava, Czechoslovakia (1987).

    Google Scholar 

  160. W. H. Clark, M. J. Mastrangelo, A. M. Ainsworth, D. Berd, R. E. Bellet, and E. A. Bernardino: Current concepts of the biology of human cutaneous malignant melanoma. Adv. Cancer Res. 24, 267 (1977).

    Article  PubMed  Google Scholar 

  161. R. M. Bukowski, S. Deodhar, J. S. Hewlett, and R. Greenstreet: Randomized controlled trial of transfer factor in stage II malignant melanoma. Cancer, 51, 269 (1983).

    Article  CAS  PubMed  Google Scholar 

  162. R. M. Bukowski, J. S. Hewlett, and S. H. Deodhar: Immunotherapy of stage II malignant melanoma and renal cell carcinoma with transfer factor in clinical results in Immune Regulators in Transfer Factor, p. 581–90, ed. by A. Khan, C. H. Kirkpatrick, N. O. Hill. Academic Press; New York (1987).

    Google Scholar 

  163. R. M. Vetto, D. R. Burger, J. E. Nolte, A. A. Vandenbark: Transfer factor immunotherapy in cancer in Transfer Factor: Basic Properties and Clinical Applications, p. 523–36, ed. M. S. Asher, A. A. Gottlieb, C. H. Kirkpatrick. Academic Press; New York (1976).

    Google Scholar 

  164. V. S. Byers, A. S. Levin, A. J. Hackett, H. H. Fudenberg: Tumor-specific cell mediated immunity in household contacts of cancer patients. J. Clin. Invest, 55, 500 (1975).

    Article  CAS  PubMed  Google Scholar 

  165. A. Levin, V. Byers, H. H. Fudenberg: Unpublished observations (1982).

    Google Scholar 

  166. H. H. Fudenberg, K. Y. Tsang: In utero osteosarcoma tolerized hamsters: a model for human cancer and immunocyte differentiation, p. 23–43, in Theories and Models in Cellular Transformation, ed. L. Saanti, L. Zardi. Academic Press; London, England (1985) (Proceedings Scientific Celebration: A. Nobel’s 150th birthday).

    Google Scholar 

  167. K. Y. Tsang, H. H. Fudenberg, and J. F. Pan: Transfer of osteosarcoma specific cell-mediated immunity in hamsters by rabbit dialyzable leukocyte extracts. Cell Immunol, 90, 295 (1985).

    Article  CAS  PubMed  Google Scholar 

  168. F. Corrado, G. Pizza, G. Severini, C. DeVinci, S. Casanova, D. Menniti, G. Corrado, P. Mauer: Immunochirurgia del tumori vescicali in Chirurgia e Immunitá, p. 317–27, ed. G. Balbo, E. C. Farina. Edizioni Masson; Milano, Italy (1988).

    Google Scholar 

  169. G. Pizza, G. Corrado, C. DeVinci, V. Fornarola, F. Corrado: Prospettive del trattamento immunologico del carcinoma renale in E Tumori Urologici: Recenti Progressi e Nuovi Obbiettivi Delia Ricerca, p. 223–32, ed. F. Corrado, et al. Monduzzi Editore; Bologna, Italy (1992).

    Google Scholar 

  170. F. K. Nkruman, G. Pizza, J. Neequaye, D. Viza, C. DeVinci, P. H. Levine: Transfer factor in prevention of Burkitt’s lymphoma relapses. J. Exp. Pathol., 3, 463–69 (1987).

    Google Scholar 

  171. W. Wei-zhong, S. Rong-wu, K. Xi-xiong, B. Li-qi, Y. De-fa, W. Wei, J. Hui-rong. W. Biao, Z. Ji-sheng: The effects of swine spleen transfer factor on the subset of T-lymphocyte and cell factor in the patients with cancer of large intestine in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 360–6, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi. Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  172. He Guangfa, Mu Yuande: Production of transfer factor from human leucocytes and its Clinical Application in Research and Application of Transfer Factor and DLE, p. 446–7, ed. Huo Bao-lai, Wang Ru-zhang, Zou Zhao-fen. Xueyuan Press; Beijing, China (1989).

    Google Scholar 

  173. B. Massayuki, T. Fujisawa, Y. Yamaguchi, H. Kimura, M. Shiba, C. Kadayama, T. Yusa: Postsurfical Adjuvant immunotherapy for non-small cell lung carcinomas in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 367–374, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi. Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  174. L. Busutti, A. Blotta, M. Mastrorilli, G. Savorani, G. Pizza, C. DeVinci: Transfer factor adjuvant therapy in non small-cell lung carcinoma (NSCLC) after surgery and radiotherapy. J. Exp. Pathol., 5, 565–8 (1987).

    Google Scholar 

  175. T. Jujisawa, Y. Yamaguchi, H. Kimura: Randomized controlled study of leucocyte dialysate and N-CWS as an adjunct to surgical treatment for primary non-small cell carcinoma of the lung in Research and Application of Transfer Factor and DLE, p. 389–98, ed. Huo Bao-lai, Wang Ru-zhang, Zou Zhao-fen. Xueyuan Press; Beijing, China (1989).

    Google Scholar 

  176. T. Fikuvoa, H. Mareckova, O. Krystukova, K. Cech, J. Pekárek: DLE in immunosuppressed patients in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 315–22, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi. Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  177. Y Lian, Q. Bian, L. Wang, D. Chen, Z. Li: Short-term observation on administering BTF combined with 60Co radiotherapy for nasopharygeal carcinoma in Research and Application of Transfer Factor and DLE, p. 319–24, ed. Huo Bao-lai, Wang Ruzhang, Zou Zhao-fen. Xueyuan Press; Beijing, China (1989).

    Google Scholar 

  178. O. Sibl, J. Pekárek, K. Cech, J. Svejcar: The adjuvant therapy of the nasopharyngeal tumor with transfer factor in Research and Application of Transfer Factor and DLE, p. 403–10, ed. Huo Bao-lai, Wang Ru-zhang, Zou Zhao-fen. Xueyuan Press; Beijing, China (1989).

    Google Scholar 

  179. S. K. Morrison, H. H. Fudenberg, and D. B. Vasily: Ten year survival of a patient with hypernephroma and pulmonary metastases, in preparation (1993).

    Google Scholar 

  180. F. Corrado, G. Pizza, C. DeVinci, G. Corrado: Il trattamento con transfer factor delle metastasi ossee da adenocarcinoma della prostata, p. 1233–5, in Le Metastasi, ed. F. Saccani et al. Monduzzi Editore; Bologna, Italy (1987).

    Google Scholar 

  181. H. H. Fudenberg, H. D. Whitten, P. Arnaud, N. Khansari: Hypothesis: Is Alzheimer’s Disease an immunological Disorder? Clin. Immuno. and Im munopath., 32, 127–31 (1984).

    Article  CAS  Google Scholar 

  182. H. H. Fudenberg, H. D. Whitten, P. Arnaud, N. Khansari, K. Y. Tsang, C. G. Harnes: Immune diagnosis of subset of Alzheimer’s disease with preliminary implications for immunotherapy. Biomed. Pharmacol., 38, 290–7 (1984).

    CAS  Google Scholar 

  183. H. H. Fudenberg, V. J. Singh: Implications of Immunomodulant therapy in Alzheimer’s Disease, p. 21–42, in Progress in Drug Research, ed. E. Jukker. Birkhäuser Verlag, Basel, Switzerland (1988).

    Google Scholar 

  184. H. H. Fudenberg: Hetergeneity of Alzheimer’s Disease in Proceedings of International Symposium of Neurologic Disorders. Molecular Chemistry, in press (1993).

    Google Scholar 

  185. H. H. Fudenberg, M. Coleman, R. Rosberger, H. L. Fudenberg: Immunotherapy of severe infantile onset autism. (Abstract). Clin. Res., 37, 556a (1989).

    Google Scholar 

  186. H. H. Fudenberg and V. J. Singh: Immunodiagnosis and immunotherapy in autistic children. Ann. N.Y. Acad. Sci., 540, 602–4 (1988).

    Article  PubMed  Google Scholar 

  187. H. H. Fudenberg, M. Coleman, D. Rosberger: In preparation (1993).

    Google Scholar 

  188. H. H. Fudenberg: Immunotherapy and immunodiagnosis of central nervous system disease subsets. In preparation (1993).

    Google Scholar 

  189. G. M. P. Galbraith and H.H. Fudenberg: One subset of patients with retinitis pigmentosa has immunologic defects. Clin. Immunol. Immunopathol., 31, 254 (1984).

    Article  CAS  PubMed  Google Scholar 

  190. G. M. P. Galbraith, D. Emmerson, H.H. Fudenberg, C.J. Gibbs, and D. C. Gadjusek: Antibodies to neurofilament protein in retinitis pigmentosa. J. Clin Invest., 78, 865 (1986).

    Article  CAS  PubMed  Google Scholar 

  191. S. Bahmanyar, M. C. Moreau-Dubois, P. Brown, F. Cathala, and D. C. Gadjusek: Serum antibodies to neurofilament antigens in patiens with neurological and other diseases and in healthy controls. J. Neuroimmunol, 5(2), 191 (1983).

    Article  CAS  PubMed  Google Scholar 

  192. V. K. Singh, R. P. Warren, J. D. Odell, W. L. Warren, P. Cole: Antibodies to Myelin basic protein in children with austic behavior. Brain Behav. and Immun., 7, 97–103 (1993).

    Article  CAS  Google Scholar 

  193. J. Fleishman: Personal communication (1987).

    Google Scholar 

  194. J. F. Jones, S. E. Straus: Chronic Epstein-Barr virus infection. Ann. Rev. Med., 38, 195–209 (1987).

    Article  CAS  PubMed  Google Scholar 

  195. G. Parish, D. Bell, B. Hyde, H. Rubinstein: The disease of a thousand names in The Clinical and Scientific Basis of Myalgic Encephalomyeltis Chronic Fatigue Syndrome, p. 3–4, ed. B. M. Hyde, J. Goldstine, P. Levine. The Nightingale Research Foundation; Ottawa, Ontario, Canada (1992).

    Google Scholar 

  196. H. Rubinstein: “Spasmophilia” and/or “Myalgie Encephalomyelitis”? in The Clinical and Scientific Basis of Myalgie Encephalomyeltis Chronic Fatigue Syndrome, p. 100–3, ed. B. M. Hyde, J. Goldstine, P. Levine. The Nightingale Research Foundation; Ottawa, Ontario, Canada (1992).

    Google Scholar 

  197. H. H. Fudenberg: Florence Nightingale Disease: a five year analysis of 50 patients with special emphasis on results of immunotherapy in Clinical and Scientific Basis of Myalgie Enkephalitis/Chronic Fatigue, p. 651–653, ed. B. Hyde, Ottawa U. Press; Ottawa, Canada, and Ogdensburg, NY (1992).

    Google Scholar 

  198. B. M. Hyde: Personal communication (1992).

    Google Scholar 

  199. H. H. Fudenberg: Cox constellation complex. In preparation (1993).

    Google Scholar 

  200. J. M. Dwyer, A. Lloyd, D. Wakefield: Transfer factor for chronic fatigue syndrome in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 288–91, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi, Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  201. B. Yang, Z. Li, Z. Cui, Y. Luo: Mechanisms of development of myasthenia gravis and the treatment effects of transfer factor. Int. J. Immunopharmacol. (1989).

    Google Scholar 

  202. K. Takenouchi, S. Sasakawa: Effects of dialyzable leukocyte extracts (DLE) in survical curves of subacute sclerosing panencephalitis (SSPE) patients in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 238–242, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi. Maruzen Co., Ltd., Tokyo, Japan (1992).

    Google Scholar 

  203. T. Fog, L. Pedersen, N. E. Raun, S. Kam-Hansen, E. Mellerup, et al.: Long-term transfer factor treatment of multiple sclerosis. Lancet, i (8069), 851 (1979).

    Google Scholar 

  204. A. Basten, J. D. Pollard, G.J. Stewart, J. A. Frith, J. G. Mcleod et al.: Transfer factor in treatment of multiple sclerosis. Lancet, 2, 9341 (1980).

    Google Scholar 

  205. J. Pekärek, K. Cech, O. Nevsimal, K. Baraet, S. Doutlik, O. Cervenková: The use of DLE-TF fraction with the suppressive effect in some autoaggressive diseases in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 326–332, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi. Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  206. H. H. Fudenberg, E. L. Hogan, J. M. Goust, S. W. Brostoff: Guillain-Barre syndrome, cellular immune deficiency and lymphoma: A case report. Eur. Rev. Med. Pharmacol. Sci., 3, 1–7 (1981).

    Google Scholar 

  207. F. Yizhen, S. Xiurong, H. Hongzhen, W. Shirong: Effects and immunological analysis of transfer factor (TF) and placental factor (PF) on Guillain-Barre’s syndromes (BGS) in children in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 335–338, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi. Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  208. L. Baoqun, X. Jianyang, Chengguanliang: Transfer factor and thymosin in the treatment Guillain-Barre’s syndrome in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 339–342, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi. Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  209. B. Liu, K. Diao, J. Guo, Z. Fan: Acute infectious polyneuritis treated with transfer factor in Research and Application of Transfer Factor and DLE, p. 432–6, ed. Huo Bao-lai, Wang Ru-zhang, Zou Zhao-fen. Xueyuan Press; Beijing, China (1989).

    Google Scholar 

  210. J. Rovensky, I. Rybar, M. Orlovska, L. Rauova, J. Pekárek: DLE in the therapy of juvenile chronic arthritis in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 323–5, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi. Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  211. L. Spitler, M. Ziff, H. H. Fudenberg: Unpublished observations (1972).

    Google Scholar 

  212. Xiao Xiuxin: Observation of curative effect curing scleroderma with transfer factor of health person in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 437–9, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi. Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  213. J. Rovensky, I. Mucska, R. Redhammer, J. Pekärek, P. Pruzinec: Wegener’s granulomatosis: some comments on the diagnosis and therapy in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 349–353, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi. Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  214. I. Sonkoly, I. Schroder, E. Bodolay, K. Lukacs and GY. Szegedi: Treatment of SLE with Transfer Factor Research and Application of Transfer Factor and DLE, page 430, Xueyuan Press, Beijing (1989).

    Google Scholar 

  215. W. Borkowski, S. Karpatkin: Leukocyte migration and inhibition of buffy coat from patients with autoimmune TP when exposed to normal placed: modulation by TF. Blood, 63, 83–87 (1984).

    Google Scholar 

  216. M. Karl, N. Domke, W. Franke, and G. Metzner: Immunotherapy of women with recurrent spontaneous abortions by human large pool dialyzable leukocyte extract (DLE) in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 311–314, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi, Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  217. N. Khansari, H. H. Fudenberg: Functional heterogeneity of human cord blood monocytes. J. Immunol., 19, 337–42 (1984).

    CAS  Google Scholar 

  218. J. Rovensky, I. Schroder, J. Pekârek, J. Svejcar, F. Vlcek: Transfer factor treatment in patients with psoriasis, p. 605–32, in Immune Regulators in Transfer Factor, ed. A. Khan, C. H. Kirkpatrick, N. O. Hill, Academic Press, NY (1979).

    Google Scholar 

  219. R. S. Schwartz and W. S. Jeter: Oral administration of human dialyzable transfer factor in a patient with psoriasis. Arch. Dermatol. 117, 3 (1981).

    Article  CAS  PubMed  Google Scholar 

  220. F. Vlcek, J. Rovensky, T. Urbanek, V. Svec, J. Lukac, et al.: Immunomodulatory therapy with dialyzable leukocyte extract (DLE) in psoriasis in Leukocyte Dialysates and Transfer Factor, p. 565–70, ed. V. Mayer, J. Borvak, Inst. Virol. Slovak Acad. Sci.; Bratislava, Czechoslavakia (1987).

    Google Scholar 

  221. D. Yan, Y. Xie, L. Pen, F. Qi, R. Zhong: The effect of DLE induced by psoriasis scale on psoriasis patients and their immunological function in Research and Application of Transfer Factor and DLE, p. 253–8, ed. Huo Bao-lai, Wang Ru-zhang, Zou Zhao-fen. Xueyuan Press; Beijing, China (1989).

    Google Scholar 

  222. H. H. Fudenberg, H.D. Whitten, E. Merler, O. Farmati: Is Schizophrenia an autoimmune receptor disorder? Med. Hypoth. 12, 85–92 (1983).

    Article  CAS  Google Scholar 

  223. H. H. Fudenberg, H. D. Whitten, Y. K. Chou, P. Arnaud, A. A. Shums, N. K. Khansari: Sigma receptors and autoimmune mechanisms in schizophrenia: preliminary findings and hypotheses. Biomedicine and Pharmacotherapy, 38, 285–90 (1984).

    CAS  Google Scholar 

  224. L. E. DeLisi, R. J. Weber, C. B. Pert: Are there antibodies against brain in era from schizophrenic patients? Biol. Psychiatry, 20, 94–119 (1985).

    Article  Google Scholar 

  225. D. Xie, T. Wang, B. Huo, X. Du: Clinical observation on 37 cases of chizophrenia treated with transfer factor from bovine spleen in Research and Application of Transfer Factor and DLE, p. 354–6, ed. Huo Bao-lai, ang Ru-zhang, Zou Zhao-fen. Xueyuan Press; Beijing, China (1989).

    Google Scholar 

  226. Y. Han, J. Liu, B. Huo, E. Wu: A control study of transfer factor and hlorpromazine in the Treatment of Schizophrenics in Research and pplication of Transfer Factor and DLE, p. 347–54, ed. Huo Bao-lai, ang Ru-zhang, Zou Zhao-fen. Xueyuan Press; Beijing, China (1989).

    Google Scholar 

  227. H. H. Fudenberg, M. Waisten: Dramatic results of immunotherapy in a evere schizophrenic. In preparation.

    Google Scholar 

  228. V. Kofranek, K. Barnet, J. Pekârek, K. Cech: Radioprotective effects of DLE in Research and Application of Transfer Factor and DLE, p. 306–13, ed. Huo Bao-lai, Wang Ru-zhang, Zou Zhao-fen. Xueyuan Press; Beijing, China (1989).

    Google Scholar 

  229. V. Kofranek, K. Barnet, J. Pekârek, K. Cech: The radioprotective effects of DLE-TF on BM cells in mice in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 140–4, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi, Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  230. J. J. Giambrone, P. H. Klesius, and H. H. Fudenberg: Adoptive transfer of delayed wattle reactivity in chickens with a dialyzable leukocyte extract containing transfer factor. Poultry Sci., 62(5), 767 (1983).

    CAS  Google Scholar 

  231. Liu Kui, Liu Wen: Clinical application of transfer factor of tun duck blood in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 253–55, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi. Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  232. R. Moulias: Use of murine transfer factor in AIDS. Instit. Virol., Slovak Acad. Sci.; Bratislava, Czechoslovakia (1988).

    Google Scholar 

  233. N. Bhardwaj, E. Brummer, L. G. Foster, H. S. Lawrence: Transfer of DTH to SK-SK and tetanus toxoid in BALB/c mice by TFd prepared from purified subpopulations of murine lymphocytes in Immune Regulators in Transfer Factor, p. 285, ed. Khan, et al. Academic Press; New York (1979).

    Google Scholar 

  234. P. Rifkind, J. A. Frey, E. A. Petersen, M. Dinowitz: Transfer of delayed hypersensitivity of mice to microbial antigens with dialyzable transfer factor. Infect. Immun. 16, 258–62 (1977).

    CAS  PubMed  Google Scholar 

  235. E. M. Liburd, H. R. Pabst, and W. D. Armstrong: Transfer factor in rat coccidiosis. Cell. Immunol., 5, 487 (1972).

    Article  CAS  PubMed  Google Scholar 

  236. G. B. Wilson, M. L. Morin, L. D. Stuart, A. M. Williams, et al.: Transfer of cell-mediated immunity in vitro to human lymphocytes using dialyzable leukocyte extracts from immune burros in Immunobiology of Transfer Factor, p. ????, ed. C. H. Kirkpatrick, H. S. Lawrence, D. R. Burger. Academic Press; New York (1983).

    Google Scholar 

  237. P. H. Klesius and H. H. Fudenberg: Bovine transfer factor: in vivo transfer of cell-mediated immunity to cattle with alcohol precipitates. Clin. Immunol. Immunopathol., 8, 238 (1977).

    Article  CAS  PubMed  Google Scholar 

  238. Haiyan Qi, Zhifang Wan, Chengzhi Su: HSV-1 specific transfer factor in goat leukocyte dialysates: Purification and biochemical characterization in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 145–9, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi, Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  239. Guo Xiu Li, Li Xin Min, Meng Qing Jun: Experiment and study for treatment of rheumatism using transfer factor of horse in Research and Application of Transfer Factor and DLE, p. 520–5, ed. Huo Bao-lai, Wang Ru-zhang, Zou Zhao-fen. Xueyuan Press; Beijing, China (1989).

    Google Scholar 

  240. M. R. Simon, J. Silva, D. Freier, J. Brunner, R. Williams: Tuberculin specific transfer factor in dogs. Infect. Immun., 18, 73–7 (1977).

    CAS  PubMed  Google Scholar 

  241. M. Shifrine, J. Thilsted, D. Pappagionis: Canine transfer factor in Transfer Factor: Basic Properties and Clinical Applications, p. 349, ed. Ascher, et al. Academic Press; New York (1976).

    Google Scholar 

  242. P. Baram, W. Condoulis: Studies on Rhesus monkey, non-dialyzable and dialyzable. Transplantn. Proc. 6, 209–15 (1974).

    CAS  Google Scholar 

  243. M. R. Mazaheri, A. J. Zuckerman, A. S. Hamblin, D. Dumonde: Specificity determinants of dialyzable transfer factor (DTF) in the rhesus monkey model in Immune Regulators in Transfer Factor, p. 65, ed. Khan, et al. Academic Press, New York (1979).

    Google Scholar 

  244. J. W. Eichberg, R. W. Steele, S. S. Kalter, W. T. Kniker, R. L. Heberling, J.J. Eller, A. R. Rodriguez: Cellular immunity in gnotobiotic primates induced by transfer factor. Cell Immun., 26, 114–9 (1976).

    Article  CAS  Google Scholar 

  245. P. H. Klesius, H. H. Fudenberg, C. L. Smith: Review: Comparitive studies on dialyzable leukocyte extracts containing transfer factor. Comp. Immun. Microbiol. Infec. Dis., 3, 247–260 (1981).

    Article  Google Scholar 

  246. G. B. Wilson, J. D. Fort: Interspecies transfers of cell-mediated immunity using specific immunity inducers with potency-prevention in selected diseases in Leukocyte Dialysates and Transfer Factor, p. 333–358, ed. V. Mayer, J. Borvak, Inst. Virol., Slovak Acad. Sci.: Bratislavia, Czecheslovakia (1983).

    Google Scholar 

  247. P. H. Klesius, D. F. Quails, A. L. Alston, and H. H. Fudenberg: Effects of bovine transfer factor (TF) in mouse coccidiosis (Eimeria ferrisi). Clin. Immunol. Immunopathol., 10, 214 (1978).

    Article  CAS  PubMed  Google Scholar 

  248. D. R. Burger, P. H. Klesius, A.A. Vandenbark, R. M. Vetto, and A.I. Swann: Transfer of keyhole limpet hemocyanin dermal reactivity to man with bovine TF. Cell. Immunol. 43, 192 (1979).

    Article  CAS  PubMed  Google Scholar 

  249. J. F. Jones, M. J. Schumacher, W. S. Jeter, and M. J. Hicks: Oral bovine transfer factor (OTF) use in the hyper-IgE syndrome in Immunobiology of Transfer Factor, ed. C. H. Kirkpatrick, H. S. Lawrence, D. R. Burger. Academic Press; New York.

    Google Scholar 

  250. G. B. Wilson, T. M. Welch, and H. H. Fudenberg: Human transfer factor in guinea pigs: Partial purification of the active component in Transfer Factor: Basic Properties and Clinical Applications, p. 409, ed. M. S. Ascher, A. A. Gottlieb, and C. H. Kirkpatrick. Academic Press; New York (1976).

    Google Scholar 

  251. P. Klesius: Unpublished observations (1983).

    Google Scholar 

  252. R. W. Steel, J. W. Eichberg, R. L. Heberling, J. J. Eller, S. S. Kalter, W. T. Kniker: Transfer of cellular reactivity to three nonhuman species with human and baboon transfer factor. Cell. Immun., 22, 110–20 (1976).

    Article  Google Scholar 

  253. Y. Zhan, P. Wang, D. Li: Transfer of Taekypleus Triclententus Hemocya-nin and DNP-BSA Dermal Reactivity to Human with Goose Derived Transfer Factor in Research and Application of Transfer Factor and DLE, p. 60–66, ed. Huo Bao-lai, Wang Ru-zhang, Zou Zhao-fen. Xueyuan Press; Beijing, China (1989).

    Google Scholar 

  254. C. L. Boucheix, J. Phillips, C. Piza, G. Sartorio, D. Viza: Activity of animal transfer factor in men. Lancet, 1, 198–9 (1977).

    Article  CAS  PubMed  Google Scholar 

  255. S. Tsugi, S. Oshima, M. Oshiro, T. Izumi: Studies on the “transfer factor” of tuberculin sensitivity in animals. J. Immun., 93, 838–49 (1964).

    Google Scholar 

  256. D. Viza, G. Pizza: In preparation (1993).

    Google Scholar 

  257. G. Pizza, C. Pizza, H. H. Fudenberg: In preparation (1993).

    Google Scholar 

  258. H. H. Fudenberg, G. B. Wilson, J. M. Goust, K. Nekam, and C. L. Smith: Dialyzable leukocyte extracts (transfer factor): A review of clinical results and immunologic methods for donor selection, evaluation of activities, and patient monitoring. Thymus, Thymic Hormones and T Lymphocytes. Eds. F. Aiuti and H. Wigzell, Proc. Sereno Symp. 38, 391 (1980).

    Google Scholar 

  259. S. J. Rozzo, C. F. Merryman, C. H. Kirkpatrick: Murine transfer factor: studies with genetically regulated immune responses in Research and Application of Transfer Factor and DLE, p. 140–164, ed. Huo Bao-lai, Wang Ru-zhang, Zou Zhao-fen. Xueyuan Press; Beijing, China (1989).

    Google Scholar 

  260. H. H. Fudenberg: Influence of per cent granulocytes and degree of donor-patient contact on clinical efficacy of transfer factor. Submitted.

    Google Scholar 

  261. M. P. Arala-Chaves, H. H. Fudenberg, Unpublished observations (1980).

    Google Scholar 

  262. H. H. Fudenberg: Florence Nightingale Disease (FND): A multisystem experiment of nature: Observations and speculations on etiology and pathogenesis. Submitted.

    Google Scholar 

  263. W. Jeffries: Personal communication (1987).

    Google Scholar 

  264. J. Von Hertog: Personal communication (1987).

    Google Scholar 

  265. M. Demitrack, J. Dale, E. Straus, et al.: Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J. Clin. Endocrinology and Metabolism, 73, 1224–34 (1992).

    Article  Google Scholar 

  266. J. G. Goldstein. Chronic Fatigue Syndrome Humana Press (1992) ??

    Google Scholar 

  267. L. M. Pachman, C. H. Kirkpatrick, D. B. Kaufman, R. M. Rothberg: The lack of effect of transfer factor in thymic dysplasia with immunoglobulin synthesis. J. Pediat., 84, 681–8 (1974).

    Article  CAS  PubMed  Google Scholar 

  268. M. Coleman: Personal communication (1986).

    Google Scholar 

  269. H. H. Fudenberg, N. Carrigg: Unpublished observations (1974).

    Google Scholar 

  270. H. H. Fudenberg, G. B. Wilson, and K. Y. Tsang: Evaluation of “transfer factor” potency and prediction of clinical response in Immunomodulation: New Frontiers and Advances, p. 115–30, ed. H. H. Fudenberg, H. Whitten, F. Ambrogi. Plenum; New York (1984).

    Google Scholar 

  271. D. Viza, F. Rosenfeld, J. Phillips, J. M. Vich, J. Denis, et al.: Specific bovine transfer factor for the treatment of herpes infections in Immunobiology of Transfer Factor, p. 245–59, ed. C. H. Kirkpatrick, H. S. Lawrence, D. R. Burger. Academic Press; New York (1983).

    Google Scholar 

  272. P. H. Klesius and C. H. Kirkpatrick: Dialyzable leukocyte extract containing transfer factor — its future in veterinary medicine in Immunobiology of Transfer Factor; p. 129–42, ed. C. H. Kirkpatrick, H. S. Lawrence, D. R. Burger. Academic Press; New York (1983).

    Google Scholar 

  273. G. B. Wilson, R. R. Shuler: Swine transmissible gastroenteritis specific immunity inducer (TF); clinical efficacy and licensing by the United States Department of Agriculture in Research and Application of Transfer Factor and DLE, p. 259–277, ed. Huo Bao-lai, Wang Ru-zhang, Zou Zhao-fen. Xueyuan Press; Beijing, China (1989).

    Google Scholar 

  274. G. B. Wilson, C. Poindexter, J. D. Fort, K. D. Ludden: De novo initiation of specific-cell-mediated immune responsiveness in chickens by transfer factor (specific immunity inducer) obtained from bovine colostrum and milk. Acta Virol., 32, 6 (1988).

    CAS  PubMed  Google Scholar 

  275. Texas Cattle Breeders Association; Houston, Texas: Personal communication; (1983).

    Google Scholar 

  276. B. Guo, X. Guo, S. Gao: The effect of transfer factor curing mastitis of 159 cows in Research and Application of Transfer Factor and DLE, p. 520–25, ed. Huo Bao-lai, Wang-Ru-zhang, Zou Zhao-fen. Xueyuan Press; Beijing, China (1989).

    Google Scholar 

  277. M. Cerhova, V. Podlaha, K. Cech, J. Pekárek: The use of DLE for the protection of weaning calves in Research and Application of Transfer Factor and DLE, p. 530–2, ed. Huo Bao-lai, Wang Ru-zhang, Zou Zhaofen. Xueyuan Press; Beijing, China (1989).

    Google Scholar 

  278. W. S. Jeter, R. Kibler, T. C. Soli, and C. A. L. Stephens: Oral administration of bovine and human dialyzable transfer factor to human volunteers in Immune Regulators in Transfer Factor, p. 451. New York: Academic ed. by A. Khan, C. H. Kirkpatrick, N. O. Hill.

    Google Scholar 

  279. J. Goldstein, P. H. Klesius, H. H. Fudenberg: Unpublished observations (1988).

    Google Scholar 

  280. C. H. Rossi, P. H. Klesius, H. H. Fudenberg: Unpublished observations (1979).

    Google Scholar 

  281. J. A. Mohr: The possible induction and/or acquisition of cellular hypersensitivity associated with ingestion of colostrum. J. Pediat., 82, 1062–4 (1973).

    Article  CAS  PubMed  Google Scholar 

  282. D. Viza, Cl. Boucheix, J. P. Cesarini, D. V. Ablashi, G. Armstrong, P. Levine, and G. Pizza: Characterization of a human lymphoblastoid cell line, LDV/7, used to replicate transfer factor and immune RNA. Bio. Cell, 46, 1–10 (1982).

    Google Scholar 

  283. Discussion in Research and Application of Transfer Factor and DLE, ed. Huo Bao-lai, Wang Ru-zhang, Zou Zhao-fen. Xueyuan Press; Beijing, China (1989).

    Google Scholar 

  284. Deleted in proof.

    Google Scholar 

  285. G. Tarro, H. H. Fudenberg: In preparation.

    Google Scholar 

  286. Deleted in proof.

    Google Scholar 

  287. G. V. Paddock, G. B. Wilson, F. K. Lin, N. O’Leary, H. H. Fudenberg: Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. VI. studies on the primary structure of transfer factor in Electrophoresis 81, p. 479–85, ed. R. C. Allen, P. Arnaud. Walter de Gruyter; Berlin, Germany (1981).

    Google Scholar 

  288. G.V. Paddock, G. B. Wilson, A.M. Williams, and H.H. Fudenberg: Human Transfer Factor: Exogenous labelling, purification, and role of ribonucleic acid segment in Immunobiology of Transfer Factor, ed. C. H. Kirkpatrick, H. S. Lawrence, D. R. Burger. Academic Press; New York, NY (1979).

    Google Scholar 

  289. G. B. Wilson, G. V. Paddock, and H. H. Fudenberg: Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. V. Antigen-specific lymphocyte responsiveness can be initiated by two structurally distinct polyribonucleotides. Thymus, 2, 257 (1981).

    CAS  PubMed  Google Scholar 

  290. G. B. Wilson, H. H. Fudenberg, G. V. Paddock, K. Y. Tsang, A. M. Williams, and E. Floyd: Mechanism(s) of action of human transfer factor: Insights obtained from studying “antigen liberated transfer factor” specific for tuberculin in Immunobiology of Transfer Factor, p. 331–46, ed. C. H. Kirkpatrick, H. S. Lawrence, D. R. Burger. Academic Press; New York (1983).

    Google Scholar 

  291. D. R. Burger, A. A. Vandenbark, R. M. Vetto, and P. H. Klesius: Human Transfer Factor: Specificity and structural models, p. 33–49, in Immunobiology of Transfer Factor, ed. C. H. Kirkpatrick, H. S. Lawrence, D. R. Burger. Academic Press; New York (1983).

    Google Scholar 

  292. G. V. Paddock, G. B. Wilson, H. H. Fudenberg, A. C. Wang, and R. E. Lovins: Purification and structural analysis of the Transfer Factor-like activity detected in vitro by leukocyte migration inhibition in Immune Regulators in Transfer Factor, p. 419–32, ed. A. Khan, C. H. Kirkpatrick, N. O. Hill. Academic Press; New York (1979).

    Google Scholar 

  293. C. A. Dinarello: Biology of interleukin-1. FASEB J., 2(2), 108 (1988).

    CAS  PubMed  Google Scholar 

  294. I. I. Singer, S. Scott, G. L. Hall, G. Limjuco, J. Chin, and J. A. Schmidt: Interleukin 1-beta is localized in the cytoplasmic ground substance but is largely absent from the golgi apparatus and plasma membranes of stimulated human monocytes. J. Exp. Med., 167, 389 (1988).

    Article  CAS  PubMed  Google Scholar 

  295. J. D. Ashwell: Are B-lymphocytes the principal antigen-presenting cells in vivo? J. Immunol., 140 (11), 3697 (1988).

    CAS  PubMed  Google Scholar 

  296. H. H. Fudenberg, J. R. L. Pink, A. C. Wang, and G. B. Ferrara: Basic Immunogenetics, 3rd ed. Oxford Univ. Press; New York (1984).

    Google Scholar 

  297. D. C. Gadjusek: Plenary lecture at U. of Göteborg International Symposium on Neurodegenerative Disorders, Jamaica (1993).

    Google Scholar 

  298. T. R. Cech: The chemistry of cell splicing of RNA and RNA enzymes. Science, 235, 1531 (1987).

    Google Scholar 

  299. R. M. Bennett, G. T. Gabor, and M. M. Merritt: DNA binding to human leukocytes; evidence for a receptor-mediated association, internalization, and degradation of DNA. J. Clin. Invest., 76, 1 (1985).

    Article  Google Scholar 

  300. R. M. Bennett, S. H. Hefeneider, A. Bakke, M. Merritt, C. A. Smith, et al.: The production and characterization of murine monoclonal antibodies to a DNA receptor on human leukocytes. J. Immunol., 140, 2937 (1988).

    Google Scholar 

  301. S. Saito, K. Takenouchi, S. Sasakawa: Inhibitory effects of dialyzable leukocyte extracts on cell functions of lymphocytes and other cell lines in Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts, p. 117–24, ed. T. Fujisawa, S. Sasakawa, Y. Iikura, F. Komatsu, Y. Yamaguchi. Maruzen Co., Ltd.; Tokyo, Japan (1992).

    Google Scholar 

  302. McFarlane Burnett: Personal communications (1974).

    Google Scholar 

  303. M. P. Arala-Chavez: Unpublished observations (1978).

    Google Scholar 

  304. V. Meyer: Personal communications (1987).

    Google Scholar 

  305. S. Sasakawa, K. Takenouchi, C. Matsumoto, T. Mura, S. Saito, et al.: Clinical trials of dialyzable leukocyte extract (RCTF-1) in Japan in Leukocyte Dialysates and Transfer Factor, p. 419–35 ed. V. Mayer, J. Borvak, Inst. Virol., Slovak Acad. Sci. (1987).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. NeuroImmuno Therapeutics Research Foundation, Spartanburg, SC, USA

    H. Hugh Fudenberg

  2. S. Orsola-Malpighi Hospital, Bologna, Italy

    Giancarlo Pizza

Authors
  1. H. Hugh Fudenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giancarlo Pizza
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Basel, Switzerland

    Ernst Jucker

  2. Steinweg 28, CH-4107, Ettingen, Switzerland

    Ernst Jucker

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Birkhäuser Verlag Basel (Switzerland)

About this chapter

Cite this chapter

Fudenberg, H.H., Pizza, G. (1994). Transfer factor 1993: New frontiers. In: Jucker, E. (eds) Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques, vol 42. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-7153-2_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-7153-2_7

  • Publisher Name: Birkhäuser Basel

  • Print ISBN: 978-3-0348-7155-6

  • Online ISBN: 978-3-0348-7153-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation